In adults with MI and LVEF ≥40%, β-blocker therapy reduced a composite adverse outcome at a median 3.5 y.
Where this comes from
- Record sourced from PubMed, PMID 41325614.
- Also identified by DOI 10.7326/ANNALS-25-04533-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].
Medical subject headings
- Adrenergic beta-Antagonists
- Stroke Volume
- Myocardial Infarction